227 related articles for article (PubMed ID: 34500063)
1. Acetyl-L-carnitine in chronic pain: A narrative review.
Sarzi-Puttini P; Giorgi V; Di Lascio S; Fornasari D
Pharmacol Res; 2021 Nov; 173():105874. PubMed ID: 34500063
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-L-carnitine in neuropathic pain: experimental data.
Chiechio S; Copani A; Gereau RW; Nicoletti F
CNS Drugs; 2007; 21 Suppl 1():31-8; discussion 45-6. PubMed ID: 17696591
[TBL] [Abstract][Full Text] [Related]
3. Effects of acetyl-L-carnitine in diabetic neuropathy and other geriatric disorders.
Sergi G; Pizzato S; Piovesan F; Trevisan C; Veronese N; Manzato E
Aging Clin Exp Res; 2018 Feb; 30(2):133-138. PubMed ID: 28534301
[TBL] [Abstract][Full Text] [Related]
4. Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain.
Notartomaso S; Mascio G; Bernabucci M; Zappulla C; Scarselli P; Cannella M; Imbriglio T; Gradini R; Battaglia G; Bruno V; Nicoletti F
Mol Pain; 2017 Jan; 13():1744806917697009. PubMed ID: 28326943
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond.
Onofrj M; Ciccocioppo F; Varanese S; di Muzio A; Calvani M; Chiechio S; Osio M; Thomas A
Expert Rev Neurother; 2013 Aug; 13(8):925-36. PubMed ID: 23965166
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
Leombruni P; Miniotti M; Colonna F; Sica C; Castelli L; Bruzzone M; Parisi S; Fusaro E; Sarzi-Puttini P; Atzeni F; Torta RG
Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
[TBL] [Abstract][Full Text] [Related]
7. Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: a randomized, double-blind, comparative study.
Memeo A; Loiero M
Clin Drug Investig; 2008; 28(8):495-500. PubMed ID: 18598095
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
De Grandis D
CNS Drugs; 2007; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
[TBL] [Abstract][Full Text] [Related]
9. L-Acetylcarnitine causes analgesia in mice modeling Fabry disease by up-regulating type-2 metabotropic glutamate receptors.
Formaggio F; Rimondini R; Delprete C; Scalia L; Merlo Pich E; Liguori R; Nicoletti F; Caprini M
Mol Pain; 2022; 18():17448069221087033. PubMed ID: 35255745
[TBL] [Abstract][Full Text] [Related]
10. Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies.
Vanotti A; Osio M; Mailland E; Nascimbene C; Capiluppi E; Mariani C
CNS Drugs; 2007; 21 Suppl 1():3-12; discussion 45-6. PubMed ID: 17696588
[TBL] [Abstract][Full Text] [Related]
11. The neurobiology of acetyl-L-carnitine.
Traina G
Front Biosci (Landmark Ed); 2016 Jun; 21(7):1314-29. PubMed ID: 27100509
[TBL] [Abstract][Full Text] [Related]
12. l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug.
Chiechio S; Canonico PL; Grilli M
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267192
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-L-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy.
Vivoli E; Di Cesare Mannelli L; Salvicchi A; Bartolini A; Koverech A; Nicolai R; Benatti P; Ghelardini C
Neuroscience; 2010 Jun; 167(4):1168-74. PubMed ID: 20302919
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a fixed combination of palmitoylethanolamide and acetyl-l-carnitine (PEA+ALC FC) in the treatment of neuropathies secondary to rheumatic diseases.
Parisi S; Ditto MC; Borrelli R; Fusaro E
Minerva Med; 2021 Aug; 112(4):492-499. PubMed ID: 34056884
[TBL] [Abstract][Full Text] [Related]
15. L-Acetyl-carnitine in Patients with Carpal Tunnel Syndrome: Effects on Nerve Protection, Hand Function and Pain.
Cruccu G; Di Stefano G; Fattapposta F; Jann S; Padua L; Schenone A; Truini A
CNS Drugs; 2017 Dec; 31(12):1103-1111. PubMed ID: 29264721
[TBL] [Abstract][Full Text] [Related]
16. Acetyl-L-carnitine and alpha-lipoic acid: possible neurotherapeutic agents for mood disorders?
Soczynska JK; Kennedy SH; Chow CS; Woldeyohannes HO; Konarski JZ; McIntyre RS
Expert Opin Investig Drugs; 2008 Jun; 17(6):827-43. PubMed ID: 18491985
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of mGlu2 receptors via NF-κB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine.
Cuccurazzu B; Bortolotto V; Valente MM; Ubezio F; Koverech A; Canonico PL; Grilli M
Neuropsychopharmacology; 2013 Oct; 38(11):2220-30. PubMed ID: 23670591
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials.
Li S; Li Q; Li Y; Li L; Tian H; Sun X
PLoS One; 2015; 10(3):e0119479. PubMed ID: 25751285
[TBL] [Abstract][Full Text] [Related]
19. Metabotropic receptors as targets for drugs of potential use in the treatment of neuropathic pain.
Chiechio S; Copani A; Melchiorri D; Canudas AM; Storto M; Calvani M; Nicolai R; Nicoletti F
J Endocrinol Invest; 2004; 27(6 Suppl):171-6. PubMed ID: 15481819
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine.
Chiechio S; Copani A; De Petris L; Morales ME; Nicoletti F; Gereau RW
Mol Pain; 2006 Jun; 2():20. PubMed ID: 16764720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
